眾應互聯(002464.SZ)預計MMOGA與彩量科技共產生商譽減值約10億元至13億元
格隆匯12月22日丨眾應互聯(002464.SZ)公佈,公司預計MMOGA與彩量科技在合併層面共計產生商譽減值計提金額約在10億元至13億元人民幣區間,無形資產減值計提金額約在2000萬元至4000萬元人民幣區間;結合公司資產情況,應不存在淨資產為負的情形。
根據會計準則的有關規定,因涉及金額較大,公司會聘請具有證券期貨業務資格的資產評估機構開展相關資產減值測試評估工作,並由具有證券期貨業務資格的會計師事務所確認最終減值金額。如2019年度公司計提相關資產減值準備,則將在相應合併層面影響公司2019年度淨利潤,具體影響金額將參考後續評估結果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.